APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemoperfusion

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

Selected research

Industry Growth & Trends

Global Hemoperfusion Industry Growth and Trends Forecast to 2032

Report ID 173908090119 December 202594 pages

Choose your research edition.

Industry ResearchHemoperfusion Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemoperfusion Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Hemoperfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemoperfusion Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemoperfusion Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.

China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Hemoperfusion market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hemoperfusion market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemoperfusion market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemoperfusion.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hemoperfusion market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hemoperfusion Market by Company

Jafron Biomedical

Baxter (Gambro)

Asahi-Kasei

Biosun Medical

Kaneka

Toray Medical

Cytosorbents

Aier

Zibo Kangbei

Hemoperfusion Segment by Type

Activated Carbon Adsorption

Resin Adsorption

Hemoperfusion Segment by Application

Hepatic Encephalopathy

Certain Autoimmune Diseases

Drug Overdose

Specific Intoxications

Others

Hemoperfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hemoperfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Activated Carbon Adsorption Table 2. Major Company of Resin Adsorption Table 3. Global Hemoperfusion Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 5. Global Hemoperfusion Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hemoperfusion Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hemoperfusion Sales Market Share in Value by Type (2021-2026) Table 8. Global Hemoperfusion Price by Type (2021-2026) & (USD/Unit) Table 9. Global Hemoperfusion Sales by Type (2027-2032) & (K Units) Table 10. Global Hemoperfusion Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hemoperfusion Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hemoperfusion Sales Market Share in Value by Type (2027-2032) Table 13. Global Hemoperfusion Price by Type (2027-2032) & (USD/Unit) Table 14. North America Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 15. North America Hemoperfusion Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 17. Europe Hemoperfusion Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Hemoperfusion Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 21. Latin America Hemoperfusion Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hemoperfusion Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Hemoperfusion Sales by Type (2021-2026) & (US$ Million) Table 24. Hemoperfusion Industry Trends Table 25. Hemoperfusion Industry Drivers Table 26. Hemoperfusion Industry Opportunities and Challenges Table 27. Hemoperfusion Industry Restraints Table 28. Global Hemoperfusion Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hemoperfusion Revenue Market Share by Company (2021-2026) Table 30. Global Hemoperfusion Sales by Company (2021-2026) & (K Units) Table 31. Global Hemoperfusion Sales Share by Company (2021-2026) Table 32. Global Hemoperfusion Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Hemoperfusion Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hemoperfusion Major Company Production Sites and Headquarters Table 35. Global Hemoperfusion Company, Product Type & Application Table 36. Global Hemoperfusion Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hemoperfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hemoperfusion Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hemoperfusion Sales by Region (2021-2026) & (K Units) Table 41. Global Hemoperfusion Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hemoperfusion Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hemoperfusion Sales Market Share in Value by Region (2021-2026) Table 44. Global Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Hemoperfusion Sales by Region (2027-2032) & (K Units) Table 46. Global Hemoperfusion Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hemoperfusion Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hemoperfusion Sales Market Share in Value by Region (2027-2032) Table 49. Global Hemoperfusion Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Hemoperfusion Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 52. Global Hemoperfusion Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hemoperfusion Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hemoperfusion Sales Market Share in Value by Application (2021-2026) Table 55. Global Hemoperfusion Price by Application (2021-2026) & (USD/Unit) Table 56. Global Hemoperfusion Sales by Application (2027-2032) & (K Units) Table 57. Global Hemoperfusion Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hemoperfusion Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hemoperfusion Sales Market Share in Value by Application (2027-2032) Table 60. Global Hemoperfusion Price by Application (2027-2032) & (USD/Unit) Table 61. North America Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 62. North America Hemoperfusion Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 64. Europe Hemoperfusion Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Hemoperfusion Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 68. Latin America Hemoperfusion Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hemoperfusion Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Hemoperfusion Sales by Application (2021-2026) & (US$ Million) Table 71. Jafron Biomedical Company Information Table 72. Jafron Biomedical Business Overview Table 73. Jafron Biomedical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Jafron Biomedical Hemoperfusion Product Portfolio Table 75. Jafron Biomedical Recent Development Table 76. Baxter (Gambro) Company Information Table 77. Baxter (Gambro) Business Overview Table 78. Baxter (Gambro) Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Baxter (Gambro) Hemoperfusion Product Portfolio Table 80. Baxter (Gambro) Recent Development Table 81. Asahi-Kasei Company Information Table 82. Asahi-Kasei Business Overview Table 83. Asahi-Kasei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Asahi-Kasei Hemoperfusion Product Portfolio Table 85. Asahi-Kasei Recent Development Table 86. Biosun Medical Company Information Table 87. Biosun Medical Business Overview Table 88. Biosun Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Biosun Medical Hemoperfusion Product Portfolio Table 90. Biosun Medical Recent Development Table 91. Kaneka Company Information Table 92. Kaneka Business Overview Table 93. Kaneka Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Kaneka Hemoperfusion Product Portfolio Table 95. Kaneka Recent Development Table 96. Toray Medical Company Information Table 97. Toray Medical Business Overview Table 98. Toray Medical Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Toray Medical Hemoperfusion Product Portfolio Table 100. Toray Medical Recent Development Table 101. Cytosorbents Company Information Table 102. Cytosorbents Business Overview Table 103. Cytosorbents Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Cytosorbents Hemoperfusion Product Portfolio Table 105. Cytosorbents Recent Development Table 106. Aier Company Information Table 107. Aier Business Overview Table 108. Aier Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Aier Hemoperfusion Product Portfolio Table 110. Aier Recent Development Table 111. Zibo Kangbei Company Information Table 112. Zibo Kangbei Business Overview Table 113. Zibo Kangbei Hemoperfusion Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Zibo Kangbei Hemoperfusion Product Portfolio Table 115. Zibo Kangbei Recent Development Table 116. North America Hemoperfusion Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. North America Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 118. North America Hemoperfusion Sales Market Share by Country (2021-2026) Table 119. North America Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units) Table 120. North America Hemoperfusion Sales Market Share Forecast by Country (2027-2032) Table 121. North America Hemoperfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Hemoperfusion Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Hemoperfusion Market Share by Country (2021-2026) Table 124. North America Hemoperfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Hemoperfusion Market Share Forecast by Country (2027-2032) Table 126. Europe Hemoperfusion Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Europe Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 128. Europe Hemoperfusion Sales Market Share by Country (2021-2026) Table 129. Europe Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units) Table 130. Europe Hemoperfusion Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Hemoperfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Hemoperfusion Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Hemoperfusion Market Share by Country (2021-2026) Table 134. Europe Hemoperfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Hemoperfusion Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Hemoperfusion Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 138. Asia-Pacific Hemoperfusion Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units) Table 140. Asia-Pacific Hemoperfusion Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Hemoperfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Hemoperfusion Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Hemoperfusion Market Share by Country (2021-2026) Table 144. Asia-Pacific Hemoperfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Hemoperfusion Market Share Forecast by Country (2027-2032) Table 146. Latin America Hemoperfusion Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Latin America Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 148. Latin America Hemoperfusion Sales Market Share by Country (2021-2026) Table 149. Latin America Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units) Table 150. Latin America Hemoperfusion Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Hemoperfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Hemoperfusion Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Hemoperfusion Market Share by Country (2021-2026) Table 154. Latin America Hemoperfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Hemoperfusion Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Hemoperfusion Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Hemoperfusion Sales by Country (2021-2026) & (K Units) Table 158. Middle East and Africa Hemoperfusion Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Hemoperfusion Sales Forecast by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Hemoperfusion Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Hemoperfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Hemoperfusion Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Hemoperfusion Market Share by Country (2021-2026) Table 164. Middle East and Africa Hemoperfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Hemoperfusion Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Hemoperfusion Distributors List Table 169. Hemoperfusion Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Hemoperfusion Image Figure 2. Global Hemoperfusion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemoperfusion Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemoperfusion Sales (2021-2032) & (K Units) Figure 5. Activated Carbon Adsorption Image Figure 6. Global Activated Carbon Adsorption Sales YoY Growth (2021-2032) & (K Units) Figure 7. Resin Adsorption Image Figure 8. Global Resin Adsorption Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Hemoperfusion Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hemoperfusion Market Share by Type 2025 VS 2032 Figure 11. North America Hemoperfusion Sales Market Share in Volume by Type in 2025 Figure 12. North America Hemoperfusion Sales Market Share in Value by Type in 2025 Figure 13. Europe Hemoperfusion Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hemoperfusion Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hemoperfusion Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hemoperfusion Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hemoperfusion Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hemoperfusion Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hemoperfusion Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hemoperfusion Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hemoperfusion Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hepatic Encephalopathy Image Figure 24. Global Hepatic Encephalopathy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Certain Autoimmune Diseases Image Figure 26. Global Certain Autoimmune Diseases Sales YoY Growth (2021-2032) & (K Units) Figure 27. Drug Overdose Image Figure 28. Global Drug Overdose Sales YoY Growth (2021-2032) & (K Units) Figure 29. Specific Intoxications Image Figure 30. Global Specific Intoxications Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Hemoperfusion Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Hemoperfusion Market Share by Application 2025 VS 2032 Figure 35. North America Hemoperfusion Sales Market Share in Volume by Application in 2025 Figure 36. North America Hemoperfusion Sales Market Share in Value by Application in 2025 Figure 37. Europe Hemoperfusion Sales Market Share in Volume by Application in 2025 Figure 38. Europe Hemoperfusion Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Hemoperfusion Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Hemoperfusion Sales Market Share in Value by Application in 2025 Figure 41. Latin America Hemoperfusion Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Hemoperfusion Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Hemoperfusion Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Hemoperfusion Sales Market Share in Value by Application in 2025 Figure 45. North America Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Hemoperfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Hemoperfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Hemoperfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Hemoperfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Hemoperfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Hemoperfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Hemoperfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Hemoperfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hemoperfusion Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Hemoperfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Hemoperfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Hemoperfusion Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Hemoperfusion Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Activated Carbon Adsorption
  • Resin Adsorption
Applications
  • Hepatic Encephalopathy
  • Certain Autoimmune Diseases
  • Drug Overdose
  • Specific Intoxications
  • Others
Companies covered
  • Jafron Biomedical
  • Baxter (Gambro)
  • Asahi-Kasei
  • Biosun Medical
  • Kaneka
  • Toray Medical
  • Cytosorbents
  • Aier
  • Zibo Kangbei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemoperfusion Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hemoperfusion Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hemoperfusion Market by Type
  6. 1.3.1 Activated Carbon Adsorption
  7. 1.3.2 Resin Adsorption
  8. 1.4 Global Hemoperfusion Market Size by Type
  9. 1.4.1 Global Hemoperfusion Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hemoperfusion Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hemoperfusion Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hemoperfusion Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hemoperfusion Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hemoperfusion Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hemoperfusion Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hemoperfusion Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hemoperfusion Industry Trends
  2. 2.2 Hemoperfusion Industry Drivers
  3. 2.3 Hemoperfusion Industry Opportunities and Challenges
  4. 2.4 Hemoperfusion Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hemoperfusion Revenue (2021-2026)
  2. 3.2 Global Top Players by Hemoperfusion Sales (2021-2026)
  3. 3.3 Global Top Players by Hemoperfusion Price (2021-2026)
  4. 3.4 Global Hemoperfusion Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemoperfusion Major Company Production Sites & Headquarters
  6. 3.6 Global Hemoperfusion Company, Product Type & Application
  7. 3.7 Global Hemoperfusion Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemoperfusion Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemoperfusion Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemoperfusion Tier 1, Tier 2, and Tier 3
4 Hemoperfusion Regional Status and Outlook
  1. 4.1 Global Hemoperfusion Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hemoperfusion Historic Market Size by Region
  3. 4.2.1 Global Hemoperfusion Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hemoperfusion Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hemoperfusion Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hemoperfusion Forecasted Market Size by Region
  7. 4.3.1 Global Hemoperfusion Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hemoperfusion Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hemoperfusion Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemoperfusion by Application
  1. 5.1 Hemoperfusion Market by Application
  2. 5.1.1 Hepatic Encephalopathy
  3. 5.1.2 Certain Autoimmune Diseases
  4. 5.1.3 Drug Overdose
  5. 5.1.4 Specific Intoxications
  6. 5.1.5 Others
  7. 5.2 Global Hemoperfusion Market Size by Application
  8. 5.2.1 Global Hemoperfusion Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Hemoperfusion Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Hemoperfusion Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Hemoperfusion Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Hemoperfusion Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Hemoperfusion Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Hemoperfusion Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Hemoperfusion Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Jafron Biomedical
  2. 6.1.1 Jafron Biomedical Company Information
  3. 6.1.2 Jafron Biomedical Business Overview
  4. 6.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
  6. 6.1.5 Jafron Biomedical Recent Developments
  7. 6.2 Baxter (Gambro)
  8. 6.2.1 Baxter (Gambro) Company Information
  9. 6.2.2 Baxter (Gambro) Business Overview
  10. 6.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
  12. 6.2.5 Baxter (Gambro) Recent Developments
  13. 6.3 Asahi-Kasei
  14. 6.3.1 Asahi-Kasei Company Information
  15. 6.3.2 Asahi-Kasei Business Overview
  16. 6.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
  18. 6.3.5 Asahi-Kasei Recent Developments
  19. 6.4 Biosun Medical
  20. 6.4.1 Biosun Medical Company Information
  21. 6.4.2 Biosun Medical Business Overview
  22. 6.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biosun Medical Hemoperfusion Product Portfolio
  24. 6.4.5 Biosun Medical Recent Developments
  25. 6.5 Kaneka
  26. 6.5.1 Kaneka Company Information
  27. 6.5.2 Kaneka Business Overview
  28. 6.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kaneka Hemoperfusion Product Portfolio
  30. 6.5.5 Kaneka Recent Developments
  31. 6.6 Toray Medical
  32. 6.6.1 Toray Medical Company Information
  33. 6.6.2 Toray Medical Business Overview
  34. 6.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Toray Medical Hemoperfusion Product Portfolio
  36. 6.6.5 Toray Medical Recent Developments
  37. 6.7 Cytosorbents
  38. 6.7.1 Cytosorbents Company Information
  39. 6.7.2 Cytosorbents Business Overview
  40. 6.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cytosorbents Hemoperfusion Product Portfolio
  42. 6.7.5 Cytosorbents Recent Developments
  43. 6.8 Aier
  44. 6.8.1 Aier Company Information
  45. 6.8.2 Aier Business Overview
  46. 6.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aier Hemoperfusion Product Portfolio
  48. 6.8.5 Aier Recent Developments
  49. 6.9 Zibo Kangbei
  50. 6.9.1 Zibo Kangbei Company Information
  51. 6.9.2 Zibo Kangbei Business Overview
  52. 6.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
  54. 6.9.5 Zibo Kangbei Recent Developments
7 North America by Country
  1. 7.1 North America Hemoperfusion Sales by Country
  2. 7.1.1 North America Hemoperfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hemoperfusion Sales by Country (2021-2026)
  4. 7.1.3 North America Hemoperfusion Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hemoperfusion Market Size by Country
  6. 7.2.1 North America Hemoperfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hemoperfusion Market Size by Country (2021-2026)
  8. 7.2.3 North America Hemoperfusion Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hemoperfusion Sales by Country
  2. 8.1.1 Europe Hemoperfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hemoperfusion Sales by Country (2021-2026)
  4. 8.1.3 Europe Hemoperfusion Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hemoperfusion Market Size by Country
  6. 8.2.1 Europe Hemoperfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hemoperfusion Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hemoperfusion Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hemoperfusion Sales by Country
  2. 9.1.1 Asia-Pacific Hemoperfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hemoperfusion Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hemoperfusion Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hemoperfusion Market Size by Country
  6. 9.2.1 Asia-Pacific Hemoperfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hemoperfusion Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hemoperfusion Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hemoperfusion Sales by Country
  2. 10.1.1 South America Hemoperfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hemoperfusion Sales by Country (2021-2026)
  4. 10.1.3 South America Hemoperfusion Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hemoperfusion Market Size by Country
  6. 10.2.1 South America Hemoperfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hemoperfusion Market Size by Country (2021-2026)
  8. 10.2.3 South America Hemoperfusion Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hemoperfusion Sales by Country
  2. 11.1.1 Middle East and Africa Hemoperfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hemoperfusion Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hemoperfusion Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hemoperfusion Market Size by Country
  6. 11.2.1 Middle East and Africa Hemoperfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hemoperfusion Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hemoperfusion Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hemoperfusion Value Chain Analysis
  2. 12.1.1 Hemoperfusion Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hemoperfusion Production Mode & Process
  7. 12.2 Hemoperfusion Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hemoperfusion Distributors
  10. 12.2.3 Hemoperfusion Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst